Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain.
暂无分享,去创建一个
[1] Yingkai Zhang,et al. Poly(ethylene glycol)-block-poly(d,l-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery , 2011, Journal of drug targeting.
[2] W. Hennink,et al. In Vivo Methods to Study Uptake of Nanoparticles into the Brain , 2010, Pharmaceutical Research.
[3] Rongqin Huang,et al. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[4] M A Vandelli,et al. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[5] Wenwei Tang,et al. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[6] W. Banks,et al. Transport across the Blood-Brain Barrier of Pluronic Leptin , 2010, Journal of Pharmacology and Experimental Therapeutics.
[7] J. Kreuter,et al. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[8] Shiladitya Sengupta,et al. Shape effect of carbon nanovectors on angiogenesis. , 2010, ACS nano.
[9] Chen Jiang,et al. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. , 2009, Biomaterials.
[10] Wei Feng,et al. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier. , 2009, International journal of pharmaceutics.
[11] U. Massing,et al. Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries , 2009, Journal of drug targeting.
[12] D. Begley,et al. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[13] Guojun Bu,et al. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy , 2009, Nature Reviews Neuroscience.
[14] J. Kreuter,et al. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[15] William A Banks,et al. Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease , 2008, BMC Neuroscience.
[16] G. Golomb,et al. Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[17] S. Krähenbühl,et al. The human brain endothelial cell line hCMEC/D3 as a human blood‐brain barrier model for drug transport studies , 2008, Journal of neurochemistry.
[18] V. Labhasetwar,et al. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. , 2008, Biomaterials.
[19] R. Davey,et al. Mouse mammary tumor virus uses mouse but not human transferrin receptor 1 to reach a low pH compartment and infect cells , 2008, Virology.
[20] G. Schenk,et al. Drug targeting to the brain , 2008, Annual review of pharmacology and toxicology.
[21] R. Béliveau,et al. Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep‐2 , 2008, British journal of pharmacology.
[22] Ke-Xin Zhang,et al. Shape effects of nanoparticles conjugated with cell-penetrating peptides (HIV Tat PTD) on CHO cell uptake. , 2008, Bioconjugate chemistry.
[23] Michel Demeule,et al. Identification and Design of Peptides as a New Drug Delivery System for the Brain , 2008, Journal of Pharmacology and Experimental Therapeutics.
[24] E. Morgan,et al. Iron trafficking inside the brain , 2007, Journal of neurochemistry.
[25] E. Shusta,et al. Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation , 2007, Pharmaceutical Research.
[26] M. Vitek,et al. COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury. , 2007, Journal of neurotrauma.
[27] P. Gaillard,et al. A novel opportunity for targeted drug delivery to the brain. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[28] C. Colton,et al. Apolipoprotein E-Derived Peptides Ameliorate Clinical Disability and Inflammatory Infiltrates into the Spinal Cord in a Murine Model of Multiple Sclerosis , 2006, Journal of Pharmacology and Experimental Therapeutics.
[29] M. Michaelis,et al. Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain , 2006, Journal of Pharmacology and Experimental Therapeutics.
[30] M. Wauben,et al. Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. , 2006, Arthritis and rheumatism.
[31] A. Rawat,et al. Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles , 2006, Journal of drug targeting.
[32] J. Greenwood,et al. Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] W. Banks,et al. Antagonists of growth hormone-releasing hormone cross the blood-brain barrier : A potential applicability to treatment of brain tumors , 2005 .
[34] T. Nagai,et al. Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[35] S. Krähenbühl,et al. Targeting of daunomycin using biotinylated immunoliposomes: Pharmacokinetics, tissue distribution and in vitro pharmacological effects , 2005, Journal of drug targeting.
[36] Meindert Danhof,et al. Targeting liposomes with protein drugs to the blood-brain barrier in vitro. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[37] A. Boer,et al. Diphtheria toxin receptor-targeted brain drug delivery , 2005 .
[38] H. Kusuhara,et al. Investigation of Efflux Transport of Dehydroepiandrosterone Sulfate and Mitoxantrone at the Mouse Blood-Brain Barrier: A Minor Role of Breast Cancer Resistance Protein , 2005, Journal of Pharmacology and Experimental Therapeutics.
[39] Yiguang Jin,et al. The Effect of RMP-7 and its Derivative on Transporting Evens Blue Liposomes into the Brain , 2004, Drug delivery.
[40] P. Gaillard,et al. The role of drug transporters at the blood-brain barrier. , 2003, Annual review of pharmacology and toxicology.
[41] Peter Ramge,et al. Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier , 2002, Journal of drug targeting.
[42] W. Pardridge,et al. Brain-specific expression of an exogenous gene after i.v. administration , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[43] I. Fichtner,et al. Influence of Surface-Modifying Surfactants on the Pharmacokinetic Behavior of 14C-Poly (Methylmethacrylate) Nanoparticles in Experimental Tumor Models , 2001, Pharmaceutical Research.
[44] U. Nielsen,et al. Tumor targeting using anti-her2 immunoliposomes. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[45] S. Pizzo,et al. Downregulation of Microglial Activation by Apolipoprotein E and ApoE-Mimetic Peptides , 2001, Experimental Neurology.
[46] Y. Sawada,et al. Characteristics of Choline Transport Across the Blood-Brain Barrier in Mice: Correlation with In Vitro Data , 2000, Pharmaceutical Research.
[47] Y. Sawada,et al. Comparison of blood-brain barrier permeability in mice and rats using in situ brain perfusion technique. , 2000, American journal of physiology. Heart and circulatory physiology.
[48] A. Kastin,et al. Mahogany (1377-1428) enters brain by a saturable transport system. , 2000, The Journal of pharmacology and experimental therapeutics.
[49] B. Engelhardt,et al. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. , 2000, The Journal of pharmacology and experimental therapeutics.
[50] M. Freeman,et al. A nontoxic diphtheria toxin analogue inhibits neonatal bladder smooth muscle cell proliferation. , 2000, The Journal of urology.
[51] J. Drewe,et al. Endocytosis and Transcytosis of an Immunoliposome-Based Brain Drug Delivery System , 2000, Journal of drug targeting.
[52] C. Lok,et al. The transferrin receptor: role in health and disease. , 1999, The international journal of biochemistry & cell biology.
[53] S. Higashiyama,et al. Heparin-binding epidermal growth factor-like growth factor mRNA expression in neonatal rat brain with hypoxic/ischemic injury , 1999, Brain Research.
[54] B. Engelhardt,et al. Immunohistochemical localization of the murine transferrin receptor (TfR) on blood–tissue barriers using a novel anti-TfR monoclonal antibody , 1998, Histochemistry and Cell Biology.
[55] M. Klagsbrun,et al. Heparin-binding EGF-like growth factor. , 1997, Biochimica et biophysica acta.
[56] R. Schiffelers,et al. Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents. , 1997, Molecular pharmacology.
[57] John W. Park,et al. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. , 1997, Biochemistry.
[58] J. Huwyler,et al. Brain drug delivery of small molecules using immunoliposomes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[59] B. Hyman,et al. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation , 1995, Cell.
[60] W. Banks,et al. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse , 1993, Journal of Neuroimmunology.
[61] W. Pardridge,et al. Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma Proteins , 1990, Journal of neurochemistry.
[62] R. Rappuoli,et al. The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197. , 1984, Nucleic acids research.
[63] L. Huang,et al. Use of radiolabeled hexadecyl cholesteryl ether as a liposome marker , 1982, Lipids.
[64] W. Pardridge. The blood-brain barrier: Bottleneck in brain drug development , 2005, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.
[65] Robin Hull,et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes , 2001, Journal of applied toxicology : JAT.
[66] R. New,et al. Liposomes : a practical approach , 1990 .
[67] R. Schulte,et al. Expression of transferrin receptor on murine hematopoietic progenitors. , 1984, Cellular immunology.